RecruitingNot ApplicableNCT06857669

Clinical Explorative Optical Breast Investigations

Breast Cancer Diagnosis Using Optical Techniques


Sponsor

Region Skane

Enrollment

90 participants

Start Date

Dec 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This study evaluates diffuse reflectance spectroscopy and photoacoustic imaging for differentiating healthy, benign, and malignant breast tissue by identifying their optical profiles.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a special optical (light-based) imaging device to examine breast tumors — both cancerous and benign — to better understand what these tumors look like under light-based analysis, which could one day improve how breast cancer is detected and monitored. **You may be eligible if...** - You have a single breast tumor (either cancerous or benign) larger than 1 cm confirmed by biopsy - You understand spoken and written Swedish **You may NOT be eligible if...** - You have had previous breast surgery - You have received neoadjuvant chemotherapy (treatment given before surgery) - You have skin burns on the chest area Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDiffuse reflectance spectroscopy and Photoacoustic imaging,

The photoacoustic imaging/diffuse reflectance spectroscopy techniques used in this study have a broader wavelength spectrum. The photoacoustic set-up can generate an optical and an ultrasound image simultaneously.


Locations(1)

Skane University Hospital

Malmö, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06857669


Related Trials